SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-111285
Filing Date
2022-10-26
Accepted
2022-10-25 21:09:50
Documents
1
Group Members
FAIRMOUNT HEALTHCARE FUND II L.P.PETER HARWINTOMAS KISELAK

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2228932-1_sc13g.htm SC 13G 113840
  Complete submission text file 0001104659-22-111285.txt   115473
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Subject) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89198 | Film No.: 221330896
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

IRS No.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G